Table 1: Baseline characteristics for Abiraterone and Enzalutamide patients.

 

Enzalutamide

Abiraterone

p values

Number

236

127

 

Median age (range) Years

76 (57 - 93)

76 (52 - 89)

p = 0.310

Gleason prognostic group distribution:

1

2

3

4

5

Not recorded

 

6%

 6%

 8%

12%

 21%

47%

 

8%

6%

4%

6%

14%

62%

 

p = 0.576

p = 0.994

p = 0.136

p = 0.075

p = 0.091

p = 0.007

Previous lines of treatment

1

2

3

4

5

 

1%

32%

55%

10%

2%

 

2%

 35%

55%

8%

 

p = 0.235

p = 0.622

p = 0.964

p = 0.485

Median starting PSA

59 (0.03-9537)

81 (2.1-1834)

p = 0.364

Proportion chemotherapy-naïve

79%

89%

p = 0.075